Details

Last Funding Type

Series C

Last Funding Money Raised

$62.50M

Industries

Biotechnology,Medical,Pharmaceutical

Founded date

Jan 1, 2006

Number Of Employee

11 - 50

Operating Status

Close

Cogentus Pharmaceuticals, Inc., a pharmaceutical company, develops prescription pharmaceutical products in North America and Europe. It develops CGT-2168, an oral formulation that combines clopidogrel with a gastroprotectant, which reduces the gastrointestinal side effects associated with dual antiplatelet therapy. The company was founded in 2006 and is based in Menlo Park, California. On January 16, 2009, Cogentus Pharmaceuticals, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Northern District of California.